120 related articles for article (PubMed ID: 35625907)
41. Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.
Maffei ME; Salata C; Gribaudo G
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500445
[TBL] [Abstract][Full Text] [Related]
42. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
Huynh T; Wang H; Luan B
Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
[TBL] [Abstract][Full Text] [Related]
43. Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and
Elebeedy D; Elkhatib WF; Kandeil A; Ghanem A; Kutkat O; Alnajjar R; Saleh MA; Abd El Maksoud AI; Badawy I; Al-Karmalawy AA
RSC Adv; 2021 Sep; 11(47):29267-29286. PubMed ID: 35492070
[TBL] [Abstract][Full Text] [Related]
44. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
[TBL] [Abstract][Full Text] [Related]
45. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
Bhardwaj VK; Singh R; Das P; Purohit R
Comput Biol Med; 2021 Jan; 128():104117. PubMed ID: 33217661
[TBL] [Abstract][Full Text] [Related]
47. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
[TBL] [Abstract][Full Text] [Related]
48. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
[TBL] [Abstract][Full Text] [Related]
49. Discovery of a botanical compound as a broad-spectrum inhibitor against gut microbial β-glucuronidases from the Tibetan medicine Rhodiola crenulata.
Chen L; Hou XD; Zhu GH; Huang J; Guo ZB; Zhang YN; Sun JM; Ma LJ; Zhang SD; Hou J; Ge GB
Int J Biol Macromol; 2024 May; 267(Pt 1):131150. PubMed ID: 38556236
[TBL] [Abstract][Full Text] [Related]
50. Dopamine and its precursor levodopa inactivate SARS-CoV-2 main protease by forming a quinoprotein.
Hao M; He Y; Song T; Guo H; Rayman MP; Zhang J
Free Radic Biol Med; 2024 Aug; 220():167-178. PubMed ID: 38718952
[TBL] [Abstract][Full Text] [Related]
51. Composition of naturally occurring compounds decreases activity of Omicron and SARS-CoV-2 RdRp complex.
Goc A; Rath M; Niedzwiecki A
Eur J Microbiol Immunol (Bp); 2022 Jun; 12(2):39-45. PubMed ID: 35895480
[TBL] [Abstract][Full Text] [Related]
52. Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection.
Chen CY; Wang WJ; Wu CS; Wang SC; Chang WC; Hung MC
Am J Cancer Res; 2024; 14(5):2555-2569. PubMed ID: 38859869
[TBL] [Abstract][Full Text] [Related]
53. Nucleotide and nucleoside-based drugs: past, present, and future.
Abdullah Al Awadh A
Saudi J Biol Sci; 2022 Dec; 29(12):103481. PubMed ID: 36389209
[TBL] [Abstract][Full Text] [Related]
54. Author Correction: Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection.
Petitjean SJL; Chen W; Koehler M; Jimmidi R; Yang J; Mohammed D; Juniku B; Stanifer ML; Boulant S; Vincent SP; Alsteens D
Nat Commun; 2022 Jun; 13(1):3611. PubMed ID: 35750667
[No Abstract] [Full Text] [Related]
55. Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins.
And Applications BC
Bioinorg Chem Appl; 2023; 2023():9804379. PubMed ID: 37829663
[TBL] [Abstract][Full Text] [Related]
56. From Pac-Man to UltraMan.
Graham JD; Grissom CK
Crit Care Med; 2023 Mar; 51(3):415-418. PubMed ID: 36809263
[No Abstract] [Full Text] [Related]
57. The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection.
Wang Z; Yang L
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571380
[TBL] [Abstract][Full Text] [Related]
58. Small molecules in the treatment of COVID-19.
Lei S; Chen X; Wu J; Duan X; Men K
Signal Transduct Target Ther; 2022 Dec; 7(1):387. PubMed ID: 36464706
[TBL] [Abstract][Full Text] [Related]
59. Exploring new catechin derivatives as SARS-CoV-2 M
Yang Z; Wang W; Qi Y; Yang Y; Chen CH; Liu JZ; Chu GX; Bao GH
Comput Biol Med; 2022 Dec; 151(Pt A):106288. PubMed ID: 36401970
[TBL] [Abstract][Full Text] [Related]
60. An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges.
Xu X; Chen Y; Lu X; Zhang W; Fang W; Yuan L; Wang X
Biochem Pharmacol; 2022 Nov; 205():115279. PubMed ID: 36209840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
